Introduction:
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a revolutionary gene-editing technology that has the potential to transform the healthcare industry. The Global CRISPR Gene Editing Market is projected to experience substantial growth in the coming years, driven by the increasing investment in R&D activities and the rising demand for personalized medicine.
Get a sample report for free:-
Market Overview:
According to VynZ Research, the global CRISPR gene editing market was valued at USD USD 1.12 billion in 2021 and is expected to reach USD 16.75 billion by 2027, growing at a CAGR of 28.60% during the forecast period (2021-2027). The increasing prevalence of genetic disorders, the growing adoption of CRISPR technology in agricultural research, and the rising number of collaborations and partnerships among market players are some of the key factors contributing to the growth of the CRISPR gene editing market.
Application:
Based on application, the CRISPR gene editing market is segmented into genetic engineering, cell line engineering, and others. The genetic engineering segment accounted for the largest market share in 2021 and is expected to maintain its dominance during the forecast period. The increasing demand for genetically modified organisms and the rising adoption of gene therapy for the treatment of genetic disorders are driving the growth of this segment.
End User:
Based on end-user, the CRISPR gene editing market is segmented into biotechnology & pharmaceutical companies, academic & research institutes, and contract research organizations. The biotechnology & pharmaceutical companies segment accounted for the largest market share in 2021 and is expected to continue its dominance during the forecast period. The increasing investment in R&D activities and the growing focus on developing gene therapies for the treatment of various diseases are driving the growth of this segment.
Region:
Based on region, the CRISPR gene editing market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest market share in 2021 and is expected to maintain its dominance during the forecast period. The presence of a large number of biotech and pharmaceutical companies in the region, coupled with the increasing investment in R&D activities, is driving the growth of the CRISPR gene editing market in North America.
Conclusion:
In conclusion, the CRISPR gene editing market is expected to experience significant growth during the forecast period, driven by the increasing prevalence of genetic disorders, the growing adoption of CRISPR technology in agricultural research, and the rising number of collaborations and partnerships among market players. The genetic engineering segment is expected to account for the largest market share, while the biotechnology & pharmaceutical companies segment is expected to dominate the end-user segment. North America is expected to be the largest market for CRISPR gene editing during the forecast period.
About Us
Global market research company, VynZ Research provides research, analytics, and consulting services for business plans. We provide specialized market research reports based on information that was predicted and estimated by industry professionals and experts. In addition to industry experts, the top-down and bottom-up approaches, data triangulation, and other techniques enable the market research leader to validate the data and deliver a major market study.
Contact Us:
Address: H.O - 9591 Fontainebleau Blvd. 617 Miami Florida 33172 U.S.A
Phone: +91 9960 288 381
Toll Free:1 888 253 3960
Email: marketing@vynzresearch.com
Website: www.vynzresearch.com
Comments